Carolina Cimminiello

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

Alice Indini, Lorenza Di Guardo, Carolina Cimminiello et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 199 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Cancer Investigation · 2014 · 105 citations

Pharmacy, Oncology, Pharmacotherapy +12

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy

Giovanni Fucà, Teresa Beninato, Marta Bini et al. · Targeted Oncology · 2021 · 61 citations

Medicine, Immunology, Oncology +14

Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience

Alice Indini, Lorenza Di Guardo, Carolina Cimminiello et al. · Journal of Gynecologic Oncology · 2019 · 59 citations · Full text

Medicine, Immunology, Oncology +17